Breast cancer arising in a BRCA-mutated background: therapeutic implications from an animal model and drug development.
about
Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast CancerSapacitabine for cancerBRCA1 and Oxidative StressERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesImmunophenotypic predictive profiling of BRCA1-associated breast cancer.Drug therapy for hereditary cancersCo-existence of breast and ovarian cancers in BRCA germ-line mutation carriers.Preoperative Systemic Treatment in BRCA-Positive Breast Cancer Patients: Case Report and Review of the Literature.BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.Herceptin resistance database for understanding mechanism of resistance in breast cancer patients.Relapsed triple-negative breast cancer: challenges and treatment strategies.In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma.Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin.
P2860
Q26744566-6C91B351-AB9F-44F7-AB80-3C140E22F44EQ27024675-040DB50C-293F-4C9C-8D48-05E9B20226A9Q28388921-9AA7FD2B-EDA0-4611-A409-97A08BB140A3Q34119028-7F545C42-06B3-4E02-8CED-C316569E9C1DQ34467646-7A6F6A03-321E-4651-82AD-121E2797EC77Q35208929-67DDEDBE-1406-42AA-A7EA-8584900F2FA2Q35602265-93C5890C-C6B5-43EE-B945-47714C36C7CCQ35976084-595DD107-0B84-49D2-9EAC-085B89BCE508Q36406519-CFFA1FE3-825A-480E-A534-3DB3D6151B42Q36652248-7AFA2395-DD2D-49D2-A55A-CF272FB3B71FQ37666730-CC6C85F9-10D3-4A7D-A78C-7FD0C6B2114EQ38120666-D68B6D80-4F80-4C45-B3D0-40779037CA51Q39220761-1E2ACE6C-31C5-4C1C-8CD2-02B186517AFDQ43264870-FB0D5260-84A2-44E5-915F-D76A81328085Q44225452-F55E00F9-D45E-4954-A921-C62519F03A8E
P2860
Breast cancer arising in a BRCA-mutated background: therapeutic implications from an animal model and drug development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Breast cancer arising in a BRC ...... al model and drug development.
@en
Breast cancer arising in a BRC ...... al model and drug development.
@nl
type
label
Breast cancer arising in a BRC ...... al model and drug development.
@en
Breast cancer arising in a BRC ...... al model and drug development.
@nl
prefLabel
Breast cancer arising in a BRC ...... al model and drug development.
@en
Breast cancer arising in a BRC ...... al model and drug development.
@nl
P356
P1433
P1476
Breast cancer arising in a BRC ...... al model and drug development.
@en
P2093
P304
P356
10.1093/ANNONC/MDN669
P577
2009-01-15T00:00:00Z